EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.2.2.19 | Ataxia |
30100084 |
Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome. |
therapeutic application unassigned |
1 0 |
3.2.2.19 | Ataxia |
30388405 |
Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome. |
therapeutic application unassigned |
1 0 |
3.2.2.19 | Ataxia |
32746785 |
Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report. |
causal interaction unassigned |
3 0 |
3.2.2.19 | Breast Neoplasms |
23736962 |
Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome. |
causal interaction diagnostic usage ongoing research unassigned |
3 4 2 0 |
3.2.2.19 | Carcinogenesis |
21697277 |
ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis. |
diagnostic usage ongoing research therapeutic application unassigned |
3 3 1 0 |
3.2.2.19 | Carcinogenesis |
33854592 |
ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma. |
causal interaction ongoing research unassigned |
4 3 0 |
3.2.2.19 | Cholera |
7896743 |
ADP-ribosylarginine glycohydrolase catalyzing the release of ADP-ribose from the cholera toxin-modified alpha-subunits of GTP-binding proteins. |
ongoing research unassigned |
1 0 |
3.2.2.19 | Cholera |
30500844 |
Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice. |
ongoing research therapeutic application unassigned |
4 1 0 |
3.2.2.19 | Communicable Diseases |
29566066 |
Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious diseases. |
causal interaction unassigned |
2 0 |
3.2.2.19 | Cystic Fibrosis |
32737883 |
A comprehensive review of therapeutic approaches available for the treatment of cholera. |
therapeutic application unassigned |
1 0 |